HawkEye 360 10-Q Reveals Material Weaknesses and Insider Selling Plans
HAWK sits 36% above its 52-week low of $17.02.
Summary
HawkEye 360's 10-Q confirms strong Q2 revenue growth but discloses material weaknesses in internal controls and insider 10b5-1 selling plans covering up to 1.5 million shares.
Key Events · Earnings and Guidance · HAWK
-
Material Weaknesses Disclosed
Management concluded disclosure controls and procedures were not effective as of June 30, 2026, due to material weaknesses at HawkEye 360 (stock option compensation expense controls) and ISA (segregation of duties and IT general controls).
-
Insider 10b5-1 Selling Plans
Nine insiders, including the CEO, CFO, and COO, adopted Rule 10b5-1 trading plans on May 21-22, 2026, covering up to 1,515,611 shares, with expiration dates ranging from December 2026 to March 2028.
-
Strong Q2 Revenue Growth
Q2 2026 revenue was $49.8 million, up 87% year-over-year, driven by the ISA acquisition and international sales growth of 134%.
-
Liquidity and Backlog
Cash and cash equivalents totaled $503.4 million as of June 30, 2026, with a $125 million undrawn revolving credit facility and a backlog of $292.2 million, including a $100 million dedicated access contract through 2032.
Analysis · HAWK · Technology
The 10-Q confirms Q2 revenue of $49.8 million, up 87% year-over-year, but the real story is the disclosure of material weaknesses in internal control over financial reporting at both HawkEye 360 and its ISA subsidiary. Management concluded disclosure controls were not effective as of June 30, 2026. Additionally, nine insiders adopted Rule 10b5-1 trading plans in May 2026, covering up to 1.5 million shares, which could create selling pressure as lock-up periods expire. The company holds $503.4 million in cash and a $292.2 million backlog, providing a strong liquidity cushion, but the control deficiencies and insider selling plans are notable governance red flags for a newly public company.
At the time of this filing, HAWK was trading at $23.11 on NYSE in the Technology sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $17.02 to $35.73. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.